We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXCP.L Regulatory News (MXCP)

  • There is currently no data for MXCP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Subscription for Loan Notes in IDE Group Holdings

10 Jan 2019 07:00

RNS Number : 6833M
MXC Capital Limited
10 January 2019
 

 

 

MXC Capital Limited

("MXC" or the "Company")

 

Subscription for Loan Notes in IDE Group Holdings plc

 

 

MXC (AIM: MXCP), the technology focused adviser and investor, announces that it has agreed to invest up to a further £9.0 million in IDE Group Holdings plc ("IDE") by way of a subscription for secured loan notes ("IDE Loan Notes") out of a total issue of £10 million. MXC currently holds 43.1 per cent. of the issued share capital of IDE.

 

The IDE Loan Notes subscription is being undertaken in two tranches. Under the first tranche, £5.3 million of IDE Loan Notes have been subscribed for; £4.3 million by MXC and £1 million by another existing shareholder of IDE (the "First Tranche Loan Notes"). £4.125 million of the proceeds of the First Tranche Loan Notes will be used to part repay IDE's £8.25 million debt facilities with National Westminster Bank plc ("Natwest") (the "Facilities") (the "First Repayment"). The second tranche of £4.7 million will be made available for subscription by all other shareholders of IDE by way of an open offer (the "Second Tranche Loan Notes") but will be underwritten by MXC. £4.125 million of the proceeds of the Second Tranche Loan Notes will be used to repay IDE's remaining debt facilities with Natwest by latest 31st March 2019 with the balance of the aggregate £10 million fundraising being used to provide additional working capital for IDE. The IDE Loan Notes will deliver longer-term funding for IDE, thereby affording security for all IDE's stakeholders.

 

Terms of the IDE Loan Notes

 

The IDE Loan Notes have a term of six years (the "Term") and an annual coupon of 12 per cent., which is rolled up, compounded annually and payable at the end of the Term. The IDE Loan Notes carry an arrangement fee of 2.5 per cent., payable at the end of Term, and an exit fee of 2.5 per cent., also payable at the end of the Term, both payable pro-rata to the subscribers of IDE Loan Notes. The IDE Loan Notes are secured on IDE's assets, though the First Tranche Loan Notes are subordinated to the Facilities with Natwest until such Facilities have been fully repaid. Thereafter the IDE Loan Notes will have first charge over IDE's assets. The IDE Loan Notes can be redeemed at any time at IDE's option, however, should IDE opt to redeem them prior to the end of the Term, all interest due until the end of the Term will become payable, together with the arrangement and exit fees, upon such early redemption.

 

The MXC Underwriting Agreement and Guarantee

 

MXC has entered into an underwriting agreement with IDE under which IDE will pay MXC a fee equal to 5 per cent. of the value of the Second Tranche Loan Notes subscribed for by it and a fee equal to 2.5 per cent. of those Second Tranche Loan Notes subscribed for by other shareholders.

 

Furthermore, MXC has also given a guarantee in favour of Natwest (the "Guarantee") whereby MXC has agreed to guarantee the amount of the Facilities which will remain outstanding following the First Repayment, being a maximum of £4.125 million. Under the guarantee MXC has, inter alia, undertaken with Natwest that if IDE does not pay any amount due under the Facilities, it shall upon demand pay that amount as if it were the principal debtor. Should Natwest call upon the Guarantee, then MXC will be issued with IDE Loan Notes equal to the amount it has paid to Natwest under the Guarantee. MXC is not receiving a fee for providing the Guarantee.

 

IDE is a mid-market network, cloud and IT managed services provider. Ian Smith, CEO of MXC, is an Executive Director of IDE and MXC Capital Markets LLP acts as financial adviser to IDE. Further details about IDE (including latest announcements and financial reports) are available at www.idegroup.com.

 

Market Abuse Regulation (MAR) Disclosure

 

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement

 

 

MXC Capital Limited

Ian Smith

+44(0)20 7965 8149

Zeus Capital Limited (Nominated adviser and broker)

Nick How

+44 (0)20 3829 5000

About MXC Capital Limited www.mxccapital.com

MXC is a specialist technology adviser and investor with a track record of investing in and advising companies in the TMT sector. MXC brings together a deep knowledge of technology, first-hand experience of managing companies in the sector, an ability to make meaningful investments and a highly experienced corporate advisory team in support, all of which combine to grow shareholder value.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGURPGUPBPUB
Date   Source Headline
19th May 20172:34 pmRNSTransaction in Own Shares / Total Voting Rights
16th May 20171:40 pmRNSTransaction in Own Shares / Total Voting Rights
15th May 201711:46 amRNSTransaction in Own Shares / Total Voting Rights
12th May 201712:08 pmRNSTransaction in Own Shares/ Total Voting Rights
11th May 201712:35 pmRNSTransaction in Own Shares/ Total Voting Rights
11th May 20179:52 amRNSTransaction in Own Shares/ Total Voting Rights
10th May 20177:26 amRNSInterim Results
5th May 20177:16 amRNSTransaction in Own Shares / Total Voting Rights
3rd Apr 20177:00 amRNSExtension of Share Buyback Programme
29th Mar 20173:18 pmRNSTransaction in Own Shares / Total Voting Rights
28th Mar 201711:50 amRNSTransaction in Own Shares / Total Voting Rights
27th Mar 20174:19 pmRNSTransaction in Own Shares / Total Voting Rights
24th Mar 20174:44 pmRNSTransaction in Own Shares/ Total Voting Rights
22nd Mar 201711:16 amRNSTransaction in Own Shares / Total Voting Rights
21st Mar 20176:29 pmRNSTransaction in Own Shares / Total Voting Rights
20th Mar 20172:20 pmRNSTransaction in Own Shares / Total Voting Rights
20th Mar 201711:08 amRNSTransaction in Own Shares / Total Voting Rights
17th Mar 20176:17 pmRNSTransaction in Own Shares / Total Voting Rights
16th Mar 201710:24 amRNSTransaction in Own Shares / Total Voting Rights
15th Mar 20179:18 amRNSTransaction in Own Shares / Total Voting Rights
14th Mar 201710:17 amRNSTransaction in Own Shares / Total Voting Rights
13th Mar 201711:04 amRNSTransaction in Own Shares / Total Voting Rights
10th Mar 20171:23 pmRNSTransaction in Own Shares / Total Voting Rights
10th Mar 201710:48 amRNSTransaction in Own Shares / Total Voting Rights
9th Mar 201710:11 amRNSTransaction in Own Shares / Total Voting Rights
9th Mar 20177:00 amRNSTrading Update
8th Mar 20177:00 amRNSIssue of Equity / Total Voting Rights
3rd Mar 20173:12 pmRNSSale of Redcentric Shares
3rd Mar 201710:47 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
3rd Mar 201710:06 amRNSSale of Redcentric Shares
2nd Mar 20179:39 amRNSTransaction in Own Shares / Total Voting Rights
1st Mar 20174:43 pmRNSTransaction in Own Shares / Total Voting Rights
1st Mar 201710:00 amRNSSale of Redcentric Shares
24th Feb 20172:31 pmRNSTransaction in Own Shares / Total Voting Rights
23rd Feb 201710:33 amRNSTransaction in Own Shares / Total Voting Rights
22nd Feb 201711:50 amRNSTransaction in Own Shares / Total Voting Rights
6th Feb 20173:22 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
6th Feb 20172:00 pmRNSSale of Redcentric Shares
26th Jan 20172:39 pmRNSResult of AGM
26th Jan 20172:18 pmRNSNotice of AGM
23rd Jan 20177:00 amRNSExercise of Redcentric Options
10th Jan 20179:42 amRNSPosting of Annual Report and Accounts
6th Jan 20174:30 pmRNSTransaction in Own Shares
5th Jan 20173:57 pmRNSTransaction in Own Shares
3rd Jan 20171:34 pmRNSTransaction in Own Shares
23rd Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 201611:16 amRNSTransaction in Own Shares
22nd Dec 20169:14 amRNSShare Buyback Programme
1st Dec 20167:00 amRNSFinal Results
23rd Nov 20167:00 amRNSResignation as Financial Adviser to Redcentric

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.